Moderna (Nasdaq:MRNA) posted first-quarter results today that beat the earnings consensus on Wall Street but slightly missed on revenue estimates.
The company reported profits of $1.2 billion, or $2.84 per share, on sales of $1.9 billion for the three months ended March 31, for a sales growth of 24112% compared with Q1 2020.
Earnings per share were $2.84, 45¢ ahead of The Street, where analysts were looking for sales of $2.04 billion.
Get the full story on our sister site, Pharmaceutical Processing World.